These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 38176716)
1. Comparison of 3 Different Therapeutic Particles in Radioembolization of Locally Advanced Intrahepatic Cholangiocarcinoma. Wagemans MEHM; Kunnen B; Stella M; van Rooij R; Smits M; Bruijnen R; Lam MGEH; de Jong HWAM; Braat AJAT J Nucl Med; 2024 Feb; 65(2):272-278. PubMed ID: 38176716 [TBL] [Abstract][Full Text] [Related]
2. Nezami N; Kokabi N; Camacho JC; Schuster DM; Xing M; Kim HS Nucl Med Biol; 2018 Apr; 59():22-28. PubMed ID: 29448165 [TBL] [Abstract][Full Text] [Related]
3. Determination of Tumor Dose Response Thresholds in Patients with Chemorefractory Intrahepatic Cholangiocarcinoma Treated with Resin and Glass-based Y90 Radioembolization. Cheng B; Villalobos A; Sethi I; Wagstaff W; Galt J; Brandon D; Schuster DM; Bercu Z; Majdalany B; Kokabi N Cardiovasc Intervent Radiol; 2021 Aug; 44(8):1194-1203. PubMed ID: 33890170 [TBL] [Abstract][Full Text] [Related]
4. High quality imaging and dosimetry for yttrium-90 ( Duan H; Khalaf MH; Ferri V; Baratto L; Srinivas SM; Sze DY; Iagaru A Eur J Nucl Med Mol Imaging; 2021 Jul; 48(8):2426-2436. PubMed ID: 33443618 [TBL] [Abstract][Full Text] [Related]
5. Dose-Response and Dose-Toxicity Relationships for Glass Alsultan AA; van Roekel C; Barentsz MW; Smits MLJ; Kunnen B; Koopman M; Braat AJAT; Bruijnen RCG; de Keizer B; Lam MGEH J Nucl Med; 2021 Nov; 62(11):1616-1623. PubMed ID: 33741643 [TBL] [Abstract][Full Text] [Related]
6. Feasibility of imaging Kunnen B; Dietze MMA; Braat AJAT; Lam MGEH; Viergever MA; de Jong HWAM Med Phys; 2020 Mar; 47(3):1105-1114. PubMed ID: 31855282 [TBL] [Abstract][Full Text] [Related]
7. Partition Model-Based 99mTc-MAA SPECT/CT Predictive Dosimetry Compared with 90Y TOF PET/CT Posttreatment Dosimetry in Radioembolization of Hepatocellular Carcinoma: A Quantitative Agreement Comparison. Gnesin S; Canetti L; Adib S; Cherbuin N; Silva Monteiro M; Bize P; Denys A; Prior JO; Baechler S; Boubaker A J Nucl Med; 2016 Nov; 57(11):1672-1678. PubMed ID: 27307346 [TBL] [Abstract][Full Text] [Related]
8. Radioembolization with (90)Y resin microspheres for intrahepatic cholangiocellular carcinoma: prognostic factors. Soydal C; Kucuk ON; Bilgic S; Ibis E Ann Nucl Med; 2016 Jan; 30(1):29-34. PubMed ID: 26370716 [TBL] [Abstract][Full Text] [Related]
9. Change in total lesion glycolysis and clinical outcome after (90)Y radioembolization in intrahepatic cholangiocarcinoma. Filippi L; Pelle G; Cianni R; Scopinaro F; Bagni O Nucl Med Biol; 2015 Jan; 42(1):59-64. PubMed ID: 25213104 [TBL] [Abstract][Full Text] [Related]
10. Insights into the Dose-Response Relationship of Radioembolization with Resin 90Y-Microspheres: A Prospective Cohort Study in Patients with Colorectal Cancer Liver Metastases. van den Hoven AF; Rosenbaum CE; Elias SG; de Jong HW; Koopman M; Verkooijen HM; Alavi A; van den Bosch MA; Lam MG J Nucl Med; 2016 Jul; 57(7):1014-9. PubMed ID: 26912436 [TBL] [Abstract][Full Text] [Related]
12. Assessment of radiation sensitivity of unresectable intrahepatic cholangiocarcinoma in a series of patients submitted to radioembolization with yttrium-90 resin microspheres. Depalo T; Traino AC; Bargellini I; Lorenzoni G; Bozzi E; Vivaldi C; Lamastra R; Masi G; Cioni R; Boni G; Volterrani D Sci Rep; 2021 Oct; 11(1):19745. PubMed ID: 34611210 [TBL] [Abstract][Full Text] [Related]
13. 18F-FDG PET independently predicts survival in patients with cholangiocellular carcinoma treated with 90Y microspheres. Haug AR; Heinemann V; Bruns CJ; Hoffmann R; Jakobs T; Bartenstein P; Hacker M Eur J Nucl Med Mol Imaging; 2011 Jun; 38(6):1037-45. PubMed ID: 21308371 [TBL] [Abstract][Full Text] [Related]
14. Segmental Yttrium-90 Radioembolization Using Glass Microspheres Greater than 400 Gray for the Treatment of Intrahepatic Cholangiocarcinoma: A Preliminary Experience. Yu Q; Patel M; Kwak D; Ungchusri E; Wang Y; Van Ha T; Zangan S; Marshall E; Little K; Baker T; Liao CY; Pillai A; Ahmed O J Vasc Interv Radiol; 2023 Nov; 34(11):1970-1976.e1. PubMed ID: 37532096 [TBL] [Abstract][Full Text] [Related]
15. Multimodality imaging can predict the metabolic response of unresectable colorectal liver metastases to radioembolization therapy with Yttrium-90 labeled resin microspheres. Flamen P; Vanderlinden B; Delatte P; Ghanem G; Ameye L; Van Den Eynde M; Hendlisz A Phys Med Biol; 2008 Nov; 53(22):6591-603. PubMed ID: 18978442 [TBL] [Abstract][Full Text] [Related]
16. PET/CT-Based Dosimetry in 90Y-Microsphere Selective Internal Radiation Therapy: Single Cohort Comparison With Pretreatment Planning on (99m)Tc-MAA Imaging and Correlation With Treatment Efficacy. Song YS; Paeng JC; Kim HC; Chung JW; Cheon GJ; Chung JK; Lee DS; Kang KW Medicine (Baltimore); 2015 Jun; 94(23):e945. PubMed ID: 26061323 [TBL] [Abstract][Full Text] [Related]
17. Radioembolization with Ho CL; Chen S; Cheung SK; Leung YL; Cheng KC; Wong KN; Wong YH; Leung TWT Eur J Nucl Med Mol Imaging; 2018 Nov; 45(12):2110-2121. PubMed ID: 29948107 [TBL] [Abstract][Full Text] [Related]
18. A deep-learning-based prediction model for the biodistribution of Plachouris D; Tzolas I; Gatos I; Papadimitroulas P; Spyridonidis T; Apostolopoulos D; Papathanasiou N; Visvikis D; Plachouri KM; Hazle JD; Kagadis GC Med Phys; 2021 Nov; 48(11):7427-7438. PubMed ID: 34628667 [TBL] [Abstract][Full Text] [Related]